Interpreting Nonrandomized Clinical Trial Data in Low-Grade Sarcoma: Differentiating Clinical Benefit From Indolent

Evan Rosenbaum1, Sujana Movva1, Ciara Kelly1

  • 1Evan Rosenbaum, MD, Sujana Movva, MD, and Ciara Kelly, MBBCh, BAO, Memorial Sloan Kettering Cancer Center, Department of Medicine, New York, NY, Weill-Cornell Medical College, Department of Medicine, New York, NY.

Abstract

No abstract available in PubMed .